Discover 1,425 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,425
FeaturedActive & Responsive
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
for
Overweight, Prediabetic State, Prehypertension,
Location: St. Petersburg FL, Orlando FL, Oviedo FL, Ocala FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07794579
Phase 3, Recruiting
FeaturedActive & Responsive
Cardiovascular Disease Studies for Adults With High Blood Pressure, High Cholesterol, AFib, or Heart Failure
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Bradenton FL, Sarasota FL, St. Petersburg FL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Bradenton FL, Lakewood Rch FL, Sarasota FL, Largo FL,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Bradenton FL, Lakewood Rch FL, Sarasota FL, Largo FL,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
for
Diabetic Peripheral Neuropathic Pain
Location: Bradenton FL, New Port Richey FL, The Villages FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07285018
Phase 2, Recruiting
Active & Responsive
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
for
Insomnia
Location: Bradenton FL, Savannah GA, Charleston SC, Richmond VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70
Code: NCT06655883
Phase 3, Recruiting
Active & Responsive
A Study of Brenipatide in Participants With Opioid Use Disorder
for
Opioid Use Disorder
Location: Bradenton FL, Tampa FL, Port Charlotte FL, Lakeland FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07420283
Phase 2, Recruiting
Active & Responsive
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
for
Osteoarthritis, Knee, Diabetic Neuropathic Pain,
Location: Bradenton FL, New Port Richey FL, The Villages FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05986292
Phase 2, Recruiting
Active & Responsive
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Location: Bradenton FL, Winston-Salem NC, O'Fallon IL,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06538064
Recruiting
Active & Responsive
Investigating Health Impacts of Exposure to Harmful Algal Blooms
for
Red Tide, Neurologic Disorder, Florida
Location: Sarasota FL
Sponsor: Roskamp Institute Inc.
Sex: All
Age: 18+
Code: NCT06883227
Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Lakewood Rch FL, Tampa FL, Clearwater FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: University Park FL, Tampa FL, Fort Myers FL,